Literature DB >> 2197879

Plasma profiles of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs.

D R LeMay1, L G LeMay, M J Kluger, L G D'Alecy.   

Abstract

This study was designed to test the tumor necrosis factor (TNF) WEHI 164 clone 13 bioassay and the interleukin 6 (IL-6) B9 bioassay for sensitivity to endogenously produced dog TNF and IL-6 and then to use these assays to examine the associations between these cytokines and lipopolysaccharide (LPS)-induced fever. When dogs were injected with LPS (40, 10, 1, 0.1, and 0.01 microgram/kg), the resulting fever was dose dependent. A plot of plasma cytokine changes over time following LPS injections showed that the plasma TNF-like activity appeared to increase in an all-or-none dose response, whereas the increase in plasma IL-6-like activity appeared to be log dose dependent. Plasma TNF-like and IL-6-like activity were then separately plotted against temperature change (fever). Statistical analysis supported the interpretation that both TNF-like and IL-6-like activity were related to LPS-fever in an all-or-none manner, with IL-6 having a threshold region. We conclude that if these cytokines are circulating mediators of fever, they may induce fever in an all-or-none fashion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197879     DOI: 10.1152/ajpregu.1990.259.1.R126

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Role of endotoxin in alterations of hepatic drug metabolism by diphtheria and tetanus toxoids and pertussis vaccine adsorbed.

Authors:  S Ansher; W Thompson; P Snoy; W Habig
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

2.  Extrahepatic ischemia-reperfusion injury reduces hepatic oxidative drug metabolism as determined by serial antipyrine clearance.

Authors:  B J Gurley; G W Barone; K Yamashita; S Polston; M Estes; A Harden
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

3.  Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog.

Authors:  T Knudsen; A T Kristensen; T C Nichols; H Agersø; A L Jensen; M Kjalke; M Ezban; M Tranholm
Journal:  Haemophilia       Date:  2011-06-06       Impact factor: 4.287

4.  The decrease in nonsplenic interleukin-6 (IL-6) production after splenectomy indicates the existence of a positive feedback loop of IL-6 production during endotoxemia in dogs.

Authors:  H S Moeniralam; W A Bemelman; E Endert; R Koopmans; H P Sauerwein; J A Romijn
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

Review 5.  Physiological and pathological roles of interleukin-6 in the central nervous system.

Authors:  D L Gruol; T E Nelson
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

6.  Circulating interleukin-6 mediates the febrile response to localised inflammation in rats.

Authors:  T Cartmell; S Poole; A V Turnbull; N J Rothwell; G N Luheshi
Journal:  J Physiol       Date:  2000-08-01       Impact factor: 5.182

7.  Pertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed.

Authors:  S Ansher; W Thompson; J Bridgewater; P Snoy
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Dysregulation of in vitro cytokine production by monocytes during sepsis.

Authors:  C Munoz; J Carlet; C Fitting; B Misset; J P Blériot; J M Cavaillon
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  The response of hepatic angiotensinogen secretion to experimental inflammatory stimuli. A comparison with acute-phase proteins.

Authors:  C Klett; E Hackenthal
Journal:  Agents Actions       Date:  1993-03

10.  Effects of endotoxic shock in several functions of murine peritoneal macrophages.

Authors:  V M Víctor; M Miñano; N Guayerbas; M Del Río; S Medina; M De la Fuente
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.